Works matching AU Tai, Wanbo
Results: 25
Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise.
- Published in:
- Frontiers in Microbiology, 2019, p. N.PAG, doi. 10.3389/fmicb.2019.00029
- By:
- Publication type:
- Article
SARS-CoV-2 infection induces testicular injury in Rhesus macaque.
- Published in:
- Virologica Sinica (16740769), 2023, v. 38, n. 2, p. 934, doi. 10.1016/j.virs.2022.10.008
- By:
- Publication type:
- Article
SARS-CoV-2 infection induces testicular injury in Rhesus macaque.
- Published in:
- Virologica Sinica (16740769), 2022, v. 37, n. 6, p. 934, doi. 10.1016/j.virs.2022.10.008
- By:
- Publication type:
- Article
T-cell immunity: a barrier to Omicron immune evasion.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01142-4
- By:
- Publication type:
- Article
Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Infection and chronic disease activate a systemic brain-muscle signaling axis.
- Published in:
- Science Immunology, 2024, v. 9, n. 97, p. 1, doi. 10.1126/sciimmunol.adm7908
- By:
- Publication type:
- Article
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines.
- Published in:
- Nature Communications, 2016, v. 7, n. 11, p. 13473, doi. 10.1038/ncomms13473
- By:
- Publication type:
- Article
Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 11, p. 1019, doi. 10.3390/v11111019
- By:
- Publication type:
- Article
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 2, p. 166, doi. 10.3390/v11020166
- By:
- Publication type:
- Article
The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 251, doi. 10.3390/vaccines8020251
- By:
- Publication type:
- Article
Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 161, doi. 10.3390/vaccines7040161
- By:
- Publication type:
- Article
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
- Published in:
- Emerging Microbes & Infections, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41426-017-0007-8
- By:
- Publication type:
- Article
Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.
- Published in:
- Emerging Microbes & Infections, 2017, v. 6, n. 1, p. 1, doi. 10.1038/emi.2017.79
- By:
- Publication type:
- Article
A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43798-8
- By:
- Publication type:
- Article
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38751-8
- By:
- Publication type:
- Article
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37926-7
- By:
- Publication type:
- Article
Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses.
- Published in:
- 2017
- By:
- Publication type:
- Letter
A clinically used anti‐human papilloma virus agent (3‐hydroxyphthalic anhydride‐modified bovine β‐lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus.
- Published in:
- MedComm, 2024, v. 5, n. 8, p. 1, doi. 10.1002/mco2.677
- By:
- Publication type:
- Article
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
- Published in:
- Human Vaccines & Immunotherapeutics, 2017, v. 13, n. 7, p. 1615, doi. 10.1080/21645515.2017.1296994
- By:
- Publication type:
- Article
The development of Nanosota-1 as antiSARS-CoV-2 nanobody drug candidates.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.64815
- By:
- Publication type:
- Article
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009897
- By:
- Publication type:
- Article
Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1315, doi. 10.3390/vaccines12121315
- By:
- Publication type:
- Article
Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.927674
- By:
- Publication type:
- Article
Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens.
- Published in:
- Journal of Nanobiotechnology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12951-025-03156-w
- By:
- Publication type:
- Article
A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity.
- Published in:
- BMC Biology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12915-022-01344-w
- By:
- Publication type:
- Article